Jennifer Audsley

Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19).

Jennifer M Audsley, Natasha E Holmes, Francesca L Mordant, Celia Douros, Sara E Zufan, Thi HO Nguyen, Lukasz Kedzierski, Louise C Rowntree, Luca Hensen, Kanta Subbarao, Katherine Kedzierska, Suellen Nicholson, Norelle Sherry, Irani Thevarajan, Thomas Tran, Julian Druce

Journal article  |  2021  |  Infect Control Hosp Epidemiol

Therapeutics for COVID-19: established and in development

Kasha P Singh, Joe Sasadeusz, Sharon R Lewin, Jennifer Audsley

Journal article  |  2021  |  MICROBIOLOGY AUSTRALIA

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first recognised in late 2019, with over 30 0..

Integrated immune dynamics define correlates of COVID-19 severity and antibody responses

Marios Koutsakos, Louise C Rowntree, Luca Hensen, Brendon Y Chua, Carolien E van de Sandt, Jennifer R Habel, Wuji Zhang, Xiaoxiao Jia, Lukasz Kedzierski, Thomas M Ashhurst, Givanna H Putri, Felix Marsh-Wakefield, Mark N Read, Davis N Edwards, E Bridie Clemens, Chinn Yi Wong, Francesca L Mordant, Jennifer A Juno, Fatima Amanat, Jennifer Audsley, et al.

Journal article  |  2021  |  CELL REPORTS MEDICINE

SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which remains ill defined. We analyzed 85 SARS-CoV-2-..

Corrigendum to: Therapeutics for COVID-19: established and in development

Kasha P Singh, Joe Sasadeusz, Sharon R Lewin, Jennifer Audsley

Journal article  |  2021  |  Microbiology Australia

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first recognised in late 2019, with over 30 0..

Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection

Kasha P Singh, Jennifer M Zerbato, Wei Zhao, Sabine Braat, Claire Deleage, G Surekha Tennakoon, Hugh Mason, Ashanti Dantanarayana, Ajantha Rhodes, Jake W Rhodes, Joe Torresi, Andrew N Harman, Peter A Revill, Megan Crane, Jacob D Estes, Anchalee Avihingsanon, Sharon R Lewin, Jennifer Audsley

Journal article  |  2020  |  PLOS PATHOGENS

In HIV-hepatitis B virus (HBV) co-infection, adverse liver outcomes including liver fibrosis occur at higher frequency than in HBV..

Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?

Jennifer Audsley, Anchalee Avihingsanon, Margaret Littlejohn, Scott Bowden, Gail Matthews, Christopher K Fairley, Sharon R Lewin, Joe Sasadeusz

Journal article  |  2020  |  JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

BACKGROUND: Tenofovir disoproxil fumarate (TDF) is effective in suppressing HIV and hepatitis B virus (HBV) replication in HIV-HBV..

The genetic landscape of COVID-19: A South Asian perspective

Vineeth Thomas, Jennifer Audsley, Nitin Kapoor

Journal article  |  2020  |  JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION

COVID-19 has taken the world by storm in the ongoing pandemic. The virus responsible for COVID-19 disease is 'severe acute respira..

Challenges and opportunities for hepatitis B cure in the setting of HIV--hepatitis B virus co-infection

Jennifer Audsley, Joe Sasadeusz

Journal article  |  2020  |  CURRENT OPINION IN HIV AND AIDS

PURPOSE OF REVIEW: To examine issues specific to HIV--HBV co-infection that are relevant to the search for and achieving hepatitis..

HBV-related inflammation is linked to the level of genetically intact HIV proviruses

X Wang, JM Zerbato, A Avihingsanon, A Rhodes, J Audsley, K Singh, W Zhao, M Crane, S Lewin, S Palmer

Conference Proceedings  |  2019  |  Journal of Virus Eradication

Tesamorelin, liver fat, and NAFLD in the setting of HIV

Jennifer Audsley, Joe Sasadeusz, Sharon R Lewin

Journal article  |  2019  |  LANCET HIV